JPLA
PDLI

Joseph P. Lucia & Associates’s PDL BioPharma, Inc. PDLI Stock Holding History

Joseph P. Lucia & Associates’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed – – 500
2020
Q2 		$0 Hold
100
– – ﹤0.01% 522
2020
Q1 		$0 Hold
100
– – ﹤0.01% 520
2019
Q4 		$0 Hold
100
– – ﹤0.01% 498
2019
Q3 		$0 Hold
100
– – ﹤0.01% 487
2019
Q2 		$0 Buy
+100
New +$324 ﹤0.01% 478

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Joseph P. Lucia & Associates's PDLI Position: Q3 2020 in Review

Joseph P. Lucia & Associates sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 100 shares.

Joseph P. Lucia & Associates first reported a position in PDLI in Q2 2019 and held it in 5 quarters. The position peaked at $0 in Q2 2020. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

  • Joseph P. Lucia & Associates reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 100 PDL BioPharma, Inc. shares in Q3 2020.
  • Joseph P. Lucia & Associates first reported a position in PDL BioPharma, Inc. in Q2 2019 and held it in 5 quarters.
  • Joseph P. Lucia & Associates's PDL BioPharma, Inc. position peaked at $0 in Q2 2020.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2020, filed 20 Oct 2020.